Table 1.
Parameter | Reference range | FFP before treatment (n = 18) |
MB plasma (n = 18) |
Percent decrease or increase |
|||
---|---|---|---|---|---|---|---|
mean ± SD | range | mean ± SD | range | mean | range | ||
TT, s | 16-21 | 21.3 ± 0.9 | 19.7–22.9 | 23.8 ± 0.9∗ | 22.3–25.1 | +11.5 | 4.4–20.1 |
RT, s | 16-22 | 18.5 ± 1.9 | 15.5–21.7 | 20.9 ± 2.4 | 17.0–24.5 | +12.7 | −11.1–48.8 |
Fibrinogen (Clauss), g/l | 1.8–4.5 | 2.4 ± 0.2 | 1.8–3.0 | 2.2 ± 0.2∗ | 1.7–2.8) | −6.9 | −13.0–0.0 |
Fibrinogen (Ag), g/l | 1.82–3.52 | 2.80 ± 0.6 | 1.60–4.23 | 2.83 ± 0.6 | 1.60–4.23 | +1.0 | −4.9–15.9 |
FV, % | 60-140 | 123.6 ± 23.6 | 88-164 | 112.8 ± 21.3∗ | 81-145 | −8.8 | −13.5 to −6.2 |
FVIII, % | 50-140 | 87.0 ± 23.0 | 48-146 | 76.8 ± 24.1∗ | 45-136 | −11.7 | −28.6–4.9 |
FXI, % | 65-150 | 117.8 ± 19.0 | 85-150 | 97.2 ± 17.8∗ | 71-135 | −17.5 | −24.1 to −10.0 |
Protein S, % | 67-132 | 85.7 ± 13.1 | 60-116 | 80.9 ± 13.0∗ | 56-108.5 | −5.6 | −10.6 to −1.0 |
p ≤0.001 compared to untreated FFP (paired t-test).